RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Collplant Biotechnologies Stock

Collplant Biotechnologies Net Income 2024

Collplant Biotechnologies Net Income

-14.66 M USD

Ticker

CLGN

ISIN

US19516R1077

WKN

A2PMPX

In 2024, Collplant Biotechnologies's profit amounted to -14.66 M USD, a 108.82% increase from the -7.02 M USD profit recorded in the previous year.

The Collplant Biotechnologies Net Income history

YEARNET INCOME (undefined USD)
2026e-291.97
2025e-4,613.21
2024e-14,657.15
2023-7,019
2022-16,930
2021240
2020-5,770
2019-11,160
2018-6,250

Collplant Biotechnologies Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Collplant Biotechnologies, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Collplant Biotechnologies from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Collplant Biotechnologies’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Collplant Biotechnologies. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Collplant Biotechnologies’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Collplant Biotechnologies’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Collplant Biotechnologies’s growth potential.

Collplant Biotechnologies Revenue, EBIT and net profit per share

DateCollplant Biotechnologies RevenueCollplant Biotechnologies EBITCollplant Biotechnologies Net Income
2026e20.24 M undefined-551,820 undefined-291,975 undefined
2025e13.26 M undefined-6.55 M undefined-4.61 M undefined
2024e1.72 M undefined-17.33 M undefined-14.66 M undefined
202310.96 M undefined-6.65 M undefined-7.02 M undefined
2022300,000 undefined-16.8 M undefined-16.93 M undefined
202115.64 M undefined440,000 undefined240,000 undefined
20206.14 M undefined-5.6 M undefined-5.77 M undefined
20192.32 M undefined-7.63 M undefined-11.16 M undefined
20185.01 M undefined-4.25 M undefined-6.25 M undefined

Collplant Biotechnologies stock margins

The Collplant Biotechnologies margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Collplant Biotechnologies. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Collplant Biotechnologies.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Collplant Biotechnologies's sales revenue. A higher gross margin percentage indicates that the Collplant Biotechnologies retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Collplant Biotechnologies's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Collplant Biotechnologies's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Collplant Biotechnologies's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Collplant Biotechnologies. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Collplant Biotechnologies's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Collplant Biotechnologies Margin History

Collplant Biotechnologies Gross marginCollplant Biotechnologies Profit marginCollplant Biotechnologies EBIT marginCollplant Biotechnologies Profit margin
2026e89.73 %-2.73 %-1.44 %
2025e89.73 %-49.4 %-34.79 %
2024e89.73 %-1,006.2 %-851.17 %
202389.73 %-60.64 %-64.05 %
202266.67 %-5,600 %-5,643.33 %
202189.51 %2.81 %1.53 %
202051.14 %-91.21 %-93.97 %
201918.97 %-328.88 %-481.03 %
201867.07 %-84.83 %-124.75 %

Collplant Biotechnologies Aktienanalyse

What does Collplant Biotechnologies do?

CollPlant Biotechnologies Ltd is a biotechnology company specializing in the development and production of collagen-based products. The company was founded in 2004 and is headquartered in Rehovot, Israel. The company's history is rooted in collagen research. Collagen is an important component of connective tissue, providing structure and strength. The company specializes in the use of plant-based collagen derived from a specific plant called Nicotiana tabacum. Plant-based collagen has the advantage of being biocompatible, biodegradable, and more cost-effective than animal-based collagen. CollPlant Biotechnologies' business model is to develop and sell collagen-based products for various industries. The company's main sectors are medicine, cosmetics, and 3D printing. Each sector offers its own products and has different requirements for collagen. In the medicine sector, CollPlant Biotechnologies offers collagen-based products for wound healing, bone regeneration, and treatment of skin diseases. The advantage of plant-based collagen is that it causes very few allergic reactions and is well tolerated. In the cosmetics sector, the company develops collagen-based products for skincare, particularly for reducing wrinkles and fine lines. CollPlant Biotechnologies also has its own cosmetics brand called "Verifeel," which offers collagen-based creams and serums. The 3D printing sector is a relatively new initiative for the company. Here, CollPlant Biotechnologies develops collagen-based materials that can be used for 3D printing of biological tissues and organs. The advantage of plant-based collagen in 3D printing is that it is highly moldable and biocompatible. CollPlant Biotechnologies also has a partnership with one of the world's largest tobacco companies, Philip Morris International. Together, they are working to produce plant-based collagen on an industrial scale. Overall, CollPlant Biotechnologies has a promising future. The company has specialized in a unique niche in the biotechnology sector and offers a variety of products for different industries. With the partnership with Philip Morris International and the development of 3D printing materials, the company also has other exciting opportunities for the future. Collplant Biotechnologies ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding Collplant Biotechnologies's Profit Margins

The profit margins of Collplant Biotechnologies represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Collplant Biotechnologies's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Collplant Biotechnologies's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Collplant Biotechnologies's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Collplant Biotechnologies’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Collplant Biotechnologies stock

How much profit has Collplant Biotechnologies made this year?

Collplant Biotechnologies has made -14.66 M USD this year.

How has the profit developed compared to last year?

The profit has increased by 108.82% compared to last year increased

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does Collplant Biotechnologies publish its earnings?

Collplant Biotechnologies publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of Collplant Biotechnologies?

The profits of Collplant Biotechnologies are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of Collplant Biotechnologies?

You can learn more about the earnings of Collplant Biotechnologies by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does Collplant Biotechnologies pay?

Over the past 12 months, Collplant Biotechnologies paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Collplant Biotechnologies is expected to pay a dividend of 0 USD.

What is the dividend yield of Collplant Biotechnologies?

The current dividend yield of Collplant Biotechnologies is .

When does Collplant Biotechnologies pay dividends?

Collplant Biotechnologies pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Collplant Biotechnologies?

Collplant Biotechnologies paid dividends every year for the past 0 years.

What is the dividend of Collplant Biotechnologies?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Collplant Biotechnologies located?

Collplant Biotechnologies is assigned to the 'Health' sector.

Wann musste ich die Aktien von Collplant Biotechnologies kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Collplant Biotechnologies from 9/27/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/27/2024.

When did Collplant Biotechnologies pay the last dividend?

The last dividend was paid out on 9/27/2024.

What was the dividend of Collplant Biotechnologies in the year 2023?

In the year 2023, Collplant Biotechnologies distributed 0 USD as dividends.

In which currency does Collplant Biotechnologies pay out the dividend?

The dividends of Collplant Biotechnologies are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Collplant Biotechnologies

Our stock analysis for Collplant Biotechnologies Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Collplant Biotechnologies Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.